The Effectiveness of Robotic Assisted Gait Training as an Adjunct to Traditional Physiotherapy in Cerebral Palsy

NCT ID: NCT04960683

Last Updated: 2022-03-25

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

41 participants

Study Classification

INTERVENTIONAL

Study Start Date

2020-11-08

Study Completion Date

2021-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Need for study

There are a few studies published on this topic from various parts of the globe and the results are mixed. Hence further research is required in this area and none of the studies have included samples from the Middle East.

Some studies done in this area focus on biomechanical aspects of gait (Cherni, 2018) and our study mainly focuses on functional aspects of gait and quality of life.

Studies done on this area focus highly on gait components and very little is available on the literature on improving balance. Since balance and stability are crucial for walking, it was decided to exclusively assess balance.

Due to a wide range of therapeutic benefits, it is paramount to evaluate the effectiveness of different therapies provided to improve gait.

Aim of the study:

The aim of the proposed research is to investigate the effectiveness of robotic assisted gait training using Lokomat device as an adjunct in improving gait, balance and quality of life in children with cerebral palsy.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Background: Gait and balance have been a major issue faced by cerebral palsy children. Cerebral Palsy is the most common condition affecting around 2-2.5 children of 1000 live births (1 in every 400 children) over the last 20 years in the Western world (Levit, 2019). Cerebral Palsy causes complex issues related to physical, psychological and social functions. Active participation and the highest level of independence during daily living are primary goals for cerebral palsy children (Aurich, 2015). One of the major problems that limits activities of daily living is relate to gait and balance in cerebral palsy. From the past one-decade, the popularity of robotic assisted gait training devices have been increasing. There are a studies published on this topic from various parts of the globe and the results are mixed. Recent publications have demonstrated robotic assisted gait training benefits people with cerebral palsy, specifically in increasing walking speed and endurance (Carvalho, 2017). However, the efficacy of robotic assisted gait training in improving gait and balance is not well researched. This study will be the first one in the United Arab Emirates studying the local population and mainly focusing on functional aspects of gait, balance and quality of life.

Aims: The main aim is to investigate the effectiveness of robotic -assisted gait training as an adjunct to traditional physiotherapy to improve gait, balance and quality of life in children with cerebral palsy.

Research hypothesis: Robotic -assisted gait training applied as adjunct to traditional therapy could improve balance, walking and quality of life in children with cerebral palsy.

Methodology: The participants attending the outpatient clinic at Zayed Higher Organization for People of Determination, Abu Dhabi will be invited to take part in the study. They will be randomly allocated to two groups. This study proposes to have 50 participants with at least 25 in each group. The participants will all have spastic form of cerebral palsy as possible with the age of 4-18 years. All the participants will have to have be at Gross Motor Function Classification Level (GMFCS) level I- IV. The robotic -assisted gait training include 5 sessions per week, of 40 min long session during one-month period. The conventional physiotherapy includes 5 sessions per week of 40 min long session during one-month period. The primary analysis will be the pre to post-test differences of the Gross Motor Function Measure (GMFM-88),dimension D \& E, 10 meters walk test, 6 minute walk test, Pediatric Balance Scale, Cerebral palsy Quality of Life questionnaire between experimental and control group.

Data analysis: Data will be statistically analysed using one-way anova. Descriptive statistics and graphic displays will be present for all outcomes for interventions comparing robotic -assisted gait training with traditional physiotherapy training.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cerebral Palsy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Robotic -assisted gait training group using Lokomat device

* 5 sessions of 40 minutes of conventional therapy and
* 5 sessions of 40 minutes on Lokomat per week

Group Type EXPERIMENTAL

Lokomat training

Intervention Type DEVICE

Control group will receive the routine conventional physiotherapy treatment and the treatment for this group consists of the following:

Conventional therapy protocol:

* 5 sessions of 45 minutes a week, each session includes:
* 5 minutes of stretching exercise
* 20 minutes of strengthening exercise
* 10 minutes of balance exercise
* 10 minutes of gait training

Experimental group will receive 45 min of Lokomat in addition to the conventional approach (as explained above). Since Lokomat appointments can be only 8 per day, it is planned to have two groups of 8 participants for 4 weeks each. The Lokomat training include the following:

* 5 sessions of 45 minutes of conventional therapy (same as above) per week
* 5 sessions of 45 minutes on Lokomat per week

Traditional therapy group

• 5 sessions of 40 minutes of conventional therapy

Group Type ACTIVE_COMPARATOR

Lokomat training

Intervention Type DEVICE

Control group will receive the routine conventional physiotherapy treatment and the treatment for this group consists of the following:

Conventional therapy protocol:

* 5 sessions of 45 minutes a week, each session includes:
* 5 minutes of stretching exercise
* 20 minutes of strengthening exercise
* 10 minutes of balance exercise
* 10 minutes of gait training

Experimental group will receive 45 min of Lokomat in addition to the conventional approach (as explained above). Since Lokomat appointments can be only 8 per day, it is planned to have two groups of 8 participants for 4 weeks each. The Lokomat training include the following:

* 5 sessions of 45 minutes of conventional therapy (same as above) per week
* 5 sessions of 45 minutes on Lokomat per week

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Lokomat training

Control group will receive the routine conventional physiotherapy treatment and the treatment for this group consists of the following:

Conventional therapy protocol:

* 5 sessions of 45 minutes a week, each session includes:
* 5 minutes of stretching exercise
* 20 minutes of strengthening exercise
* 10 minutes of balance exercise
* 10 minutes of gait training

Experimental group will receive 45 min of Lokomat in addition to the conventional approach (as explained above). Since Lokomat appointments can be only 8 per day, it is planned to have two groups of 8 participants for 4 weeks each. The Lokomat training include the following:

* 5 sessions of 45 minutes of conventional therapy (same as above) per week
* 5 sessions of 45 minutes on Lokomat per week

Intervention Type DEVICE

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Conventional therapy

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Cerebral palsy with spastic and mix form

* Gross Motor Function Classification System (GMFCS from level II to IV)
* Age 4 to 18
* No contraindications for the training in the Lokomat
* Able to follow simple instructions

Exclusion Criteria

* On botox injection within the last 6 months (as the effect of botox wear out in 6 months)

* Surgery within the last one year
* Fixed contractures and/or with bone instability
* Baclofen infusion pumps in situ
* Seizure disorder that is not controlled by medication (if on medication, must not have had a seizure in the last 12 months);
* Open skin lesions or vascular disorder of lower extremities;
* Having participated in another Lokomat training regime within the previous 3months as well as a change in concomitant treatment within the last 4 weeks before or during the study period
Minimum Eligible Age

4 Years

Maximum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Fatima College of Health Sciences

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Dragana Djuric

Instructor in physiotherapy

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Dragana Djuric

Role: PRINCIPAL_INVESTIGATOR

FCHS

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Fatima College of Health Sciences

Abu Dhabi, , United Arab Emirates

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United Arab Emirates

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

INTSTF018PHY20

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Gait Training for Persons With Stroke
NCT00612300 COMPLETED EARLY_PHASE1